Signaling pathways mediating manganese-induced toxicity in human glioblastoma cells (u87)

Shilpa Puli1, James C K Lai, Kristina L Edgley

  • 1Department of Pharmaceutical Sciences, College of Pharmacy and Biomedical Research Institute, Idaho State University, Pocatello, ID 83209, USA.

Neurochemical Research
|October 18, 2006
PubMed

Insights

Excess manganese (Mn) causes neurotoxicity by impairing energy metabolism and inducing cell death. This study reveals Mn's effects on glioblastoma cell signaling, potentially impacting invasion and apoptosis.

Area of Science:

  • Neurotoxicology
  • Cellular Signaling
  • Cancer Biology

Background:

  • Manganese (Mn) is essential but toxic in excess, causing neurotoxicity through impaired energy metabolism and cell death.
  • The precise signaling mechanisms behind Mn neurotoxicity remain largely unknown.
  • Glioblastoma multiforme is an aggressive brain tumor characterized by proliferation and invasion.

Purpose of the Study:

  • To investigate the signaling pathways affected by Mn toxicity in human glioblastoma (U87) cells.
  • To elucidate the role of Mn in glioblastoma cell proliferation, invasion, and apoptosis.
  • To explore potential therapeutic implications of Mn's effects on glioblastoma.

Main Methods:

  • Human glioblastoma (U87) cells were treated with manganese (Mn).
  • Investigated the mitogen-activated protein kinase (MAPK) and AKT signaling pathways.
  • Assessed levels of transcription factors c-Jun and c-Fos, and matrix metalloproteinase-2 (MMP-2).
  • Evaluated Mn-induced apoptosis using U87 cells.

Main Results:

  • Mn treatment down-regulated the MAPK pathway but did not significantly affect the AKT pathway.
  • Mn exposure decreased levels of c-Jun, c-Fos, and MMP-2, key factors in glioblastoma invasion.
  • Mn-induced apoptosis was observed in U87 cells.
  • Mn demonstrated differential effects on signaling pathways regulating glioblastoma proliferation and invasion.

Conclusions:

  • Manganese induces apoptosis in glioblastoma cells.
  • Mn may inhibit glioblastoma invasion by down-regulating specific signaling pathways and matrix-degrading enzymes.
  • These findings suggest Mn could have therapeutic potential in managing glioblastoma.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...